BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2398427)

  • 1. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey.
    Hosenpud JD; Uretsky BF; Griffith BP; O'Connell JB; Olivari MT; Valantine HA
    J Heart Transplant; 1990; 9(4):346-50. PubMed ID: 2398427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey.
    Hosenpud JD; DeMarco T; Frazier OH; Griffith BP; Uretsky BF; Menkis AH; O'Connell JB; Olivari MT; Valantine HA
    Circulation; 1991 Nov; 84(5 Suppl):III338-43. PubMed ID: 1934428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidosis and cardiac involvement.
    Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
    Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart transplantation in patients with amyloidosis: single-center experience.
    Alloni A; Pellegrini C; Ragni T; Goggi C; D'Armini AM; Rinaldi M; Viganò M
    Transplant Proc; 2004 Apr; 36(3):643-4. PubMed ID: 15110619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart transplantation for cardiac amyloidosis: successful one-year outcome despite recurrence of the disease.
    Conner R; Hosenpud JD; Norman DJ; Pantely GA; Cobanoglu A; Starr A
    J Heart Transplant; 1988; 7(2):165-7. PubMed ID: 3284989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
    Maurer MS; Raina A; Hesdorffer C; Bijou R; Colombo P; Deng M; Drusin R; Haythe J; Horn E; Lee SH; Marboe C; Naka Y; Schulman L; Scully B; Shapiro P; Prager K; Radhakrishnan J; Restaino S; Mancini D
    Transplantation; 2007 Mar; 83(5):539-45. PubMed ID: 17353770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
    Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
    J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of heart transplantation in patients with amyloid cardiomyopathy.
    Kpodonu J; Massad MG; Caines A; Geha AS
    J Heart Lung Transplant; 2005 Nov; 24(11):1763-5. PubMed ID: 16297778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.
    Mignot A; Varnous S; Redonnet M; Jaccard A; Epailly E; Vermes E; Boissonnat P; Gandjbakhch I; Herpin D; Touchard G; Bridoux F
    Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
    Brann WM; Bennett LE; Keck BM; Hosenpud JD
    J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of simultaneous heart and kidney transplantation with single donor allografts: report of nine cases.
    Bruschi G; Busnach G; Colombo T; Radaelli L; Pedrazzini G; Garatti A; Sansalone CV; Frigerio M; Vitali E
    Ann Thorac Surg; 2007 Aug; 84(2):522-7. PubMed ID: 17643629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
    Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL).
    Gertz MA; Lacy MQ; Gastineau DA; Inwards DJ; Chen MG; Tefferi A; Kyle RA; Litzow MR
    Bone Marrow Transplant; 2000 Nov; 26(9):963-9. PubMed ID: 11100275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal amyloidosis followed more than 5 years: report of 12 cases.
    Kaaroud H; Boubaker K; Béji S; Abderrahim E; Moussa FB; Turki S; Goucha R; Hedri H; El Younsi F; Kheder A; Maiz HB
    Transplant Proc; 2004; 36(6):1796-8. PubMed ID: 15350480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
    Perfetti V; Siena S; Palladini G; Bregni M; Di Nicola M; Obici L; Magni M; Brunetti L; Gianni AM; Merlini G
    Haematologica; 2006 Dec; 91(12):1635-43. PubMed ID: 17145600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement.
    Pellikka PA; Holmes DR; Edwards WD; Nishimura RA; Tajik AJ; Kyle RA
    Arch Intern Med; 1988 Mar; 148(3):662-6. PubMed ID: 3341867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.